Moreover, twelve months of HFD in transgenic AD mice reduced blood–brain barrier leakage and brain atrophy, improved cognition, and returned levels of insulin receptor mRNA to that of the normal wild type mice [117]. The gene discussed is INSR; the disease is Brain atrophy.